Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131810) titled 'Research and Application Demonstration on the Construction of Placenta Accreta Risk Prediction Model Based on MRI and Neural Network Technology' on Sept. 7.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region
Condition:
Placenta accreta
Intervention:
Gold Standard:Surgery and/or pathological diagnosis
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-03-01
Target Sample Size: Target condition:800;Difficult condition:50
Countries of Recruitment:
China
To know more, vis...